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Motivation incorporates several psychological aspects that produce reward-related and learning 
behaviors.  Although reward-related behavior is reported to be mediated by the dopaminergic reward 
pathway,  the involvement of dopaminergic systems in motivated behavior has not been fully clariﬁed.  
Several experimental methodologies for motivational behavior have been reported,  but pharmaco-
logical characteristics seem to vary among these methodologies.  In this review,  we attempt to sum-
marize three main concepts: (1) the relationship of dopamine neuron physiology with motivated 
behavior,  (2) the pharmacological characteristics of the runway intracranial self-stimulation model,  
and (3) the behavioral distinction of disparate motivated behaviors.
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otivation is a set of psychological characteris-
tics that elicits,  controls,  and sustains certain 
goal-directed behaviors.  A motivational deﬁcit is a 
symptom often related to several mental disorders 
such as major depression,  Parkinsonian syndrome,  and 
schizophrenia.  Many cases have been reported in 
which motivational deﬁcits are not improved even 
though the mental disorder has been treated appropri-
ately [1,  2].  Therefore,  we hypothesized that neural 
mechanisms underlying motivation may be distinct 
from the neural systems impaired in mental diseases.  
That is,  we believe that previously undescribed cen-
tral nervous system mechanisms are participating in 
motivation.
　 Motivational mechanisms are often recruited during 
reward-related learning behaviors.  As dopamine is 
well known as the main neurotransmitter that mediates 
reward-related behavior [3-5],  dopamine may par-
ticipate in motivational behaviors.  However,  the 
participation of dopamine neural transmission in moti-
vational behavior is not fully clariﬁed.  Although 
numerous experimental models for motivation have 
been described,  the participation of dopamine signal-
ing varies among these reports.
　 We previously demonstrated the feasibility of using 
a runway model that incorporates intracranial self-
stimulation (ICSS) behavior to evaluate the motiva-
tional eﬀects of drugs [6].  Speciﬁcally,  this runway 
ICSS model is able to study the reward- and motiva-
tion-based properties of operant behavior separately.  
For example,  motivated behavior in the runway ICSS 
model reﬂects distinct pharmacological aspects com-
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pared with forced swimming tests and conditioned 
place preference tests [7].
　 In this article,  we review the participation of 
dopamine neurotransmission in reward-related behav-
ior and the eﬀects of pharmacological manipulations in 
the runway model of ICSS,  which is a methodology 
developed in our laboratory to evaluate the motiva-
tional property of drugs.  In addition,  we discuss the 
characteristics of the runway model of ICSS as com-
pared with other methods of evaluating motivation.
Involvement of Dopamine Neural Activity in 
Motivated Behavior
　 It is well known that dopamine is one of the key 
neurotransmitters mediating aﬀect and reward.  Natural 
rewards such as palatable food and water or copula-
tion are reported to increase extracellular dopamine 
in the nucleus accumbens (NAc) [8-10].  Similarly,  
self-administration of abused drugs increases extra-
cellular dopamine within the NAc [11-13].  In con-
trast,  changes in dopamine during ICSS behavior are 
equivocal across studies.  Some studies found that 
dopamine levels in the NAc are increased during 
ICSS [14-17],  but other research has demonstrated 
that rats continue to press the operant ICSS lever 
without increases in dopamine in the NAc [18,  19].  
Since electrical brain stimulation directly activates 
reward-related pathways,  it is considered that ICSS 
procedures would be adequate to assess the relation-
ship between reward and dopamine neural activity.  
However,  the role of dopamine in reward-related 
behavior is controversial.  Recent studies have sug-
gested that dopamine contributes to reward prediction 
or motivational properties rather than reward itself 
during the reward-related behavior [20,  21].  Dopamine 
elevations are larger during reward prediction com-
pared to reward acquisition.  Dopamine elevations 
during reward acquisition are reduced along with 
learning about the relevance between reward and cue 
prediction [22,  23].  Therefore,  it is considered that 
dopamine mainly contributes to reward prediction or 
the motivational properties of reward-related cues.  
Motivational states in these studies may vary and dif-
ferences in dopamine elevations would reﬂect these 
motivational diﬀerences.
　 Extrasynaptic dopamine is released as a conse-
quence of neural ﬁring and consists of 2 diﬀerent 
modalities: phasic and tonic dopamine ﬁring [24,  
25].  Phasic and tonic release is related to particular 
behavioral states.  For instance,  phasic dopamine 
activity facilitates cue-reward association and acquisi-
tion of incentive salience,  whereas tonic activity is 
involved in response inhibition and behavioral ﬂexibil-
ity [26-28].  Thus,  motivational behavior may be 
regulated by phasic dopamine ﬁring.  In addition,  it has 
been considered that activation of neural systems 
regulated by dopamine receptors may be controlled by 
a combination of phasic and tonic ﬁring.  It was esti-
mated that phasic and tonic ﬁring would diﬀerently 
aﬀect dopamine D1 and D2 receptor occupancy in a 
computer simulation study [29].  Furthermore,  dop-
amine D1 and D2 receptors were reported to be dif-
ferentially involved in negative conditioned behavior 
after acute nicotine exposure or nicotine withdrawal 
[30].  Phasic dopamine ﬁring is speciﬁcally associated 
with acute nicotine exposure rather than withdrawal 
from chronic nicotine.  Thus,  it is believed that the 
reaction of dopamine receptors to released dopamine 
is complex and that dopamine receptors are diﬀerently 
activated depending on the pattern of dopamine 
release.  Dopamine receptors may respond diﬀerently 
to rewarding stimulation,  non-rewarding stimulation,  
and/or reward prediction (motivation).  Additionally,  
a unique pattern of stimulation of dopamine receptors 
may be required to facilitate motivation.
The Runway Model of ICSS
　 The runway ICSS model is a methodology that 
incorporates the ICSS procedure in a runway appara-
tus (Fig.  1).  Once rats have established ICSS behav-
ior at the goal lever,  subjects strive to maintain the 
ICSS behavior even if they are moved away from the 
lever by the experimenter.  After learning the essence 
of the runway apparatus,  rats will run toward the goal 
lever from the start box to obtain a reward.  As the 
running animals desire the goal reward,  the running 
behavior is considered to represent motivated behav-
ior.  In our previous research,  it was hypothesized 
that the runway ICSS model would be applicable to 
the assessment of the motivational eﬀects of drugs 
[6].  Moreover,  our previous research revealed the 
following behavioral characteristics and dopaminergic 
involvement in the runway ICSS model.
　 Two distinct electrical stimulations ﾝ prim-
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ing stimulation and reward stimulation.
　 In the runway ICSS experiments,  animals were 
provided 2 opportunities for receiving electrical 
stimulation: a reward stimulation after a lever press 
and a priming stimulation.  Electrical properties of 
these stimulation are the same (single train of 0.2-ms 
pulses of 60Hz alternating current).  Before each run-
ning trial,  priming stimulations are supplied at the 
priming box,  which is a distinct place unrelated to the 
running behavior.  After reaching the goal end and 
pressing the lever,  rats receive a reward stimulation.
　 The most signiﬁcant characteristic here is that 
running speed varies according to the frequency of the 
priming stimulation.  The running speed would pre-
sumably reﬂect the motivation for getting the reward 
at the goal lever.  Interestingly,  running behavior is not 
performed in a no-reward situation,  even if suﬃcient 
priming stimulation is provided (Fig.  2).  Thus,  the 
runway model of ICSS measures motivated behavior 
based on the goal reward,  although the priming stimu-
lation could still modulate the motivated behavior.
　 Postulated relationship between the runway 
model of ICSS and dopamine-mediated salience.
　 Phasic dopamine release is considered to be 
involved in the reward prediction error,  learning,  and 
motivation [31].  Cue-evoked dopamine release should 
increase in the context of motivation,  since cue-
evoked dopamine release is reported to become larger 
after animals learn the relationship between reward 
and predictive cue stimulation [23].  In the runway 
model of ICSS,  the priming stimulation is an electri-
cal stimulation of dopamine neurons that would tempo-
rarily release dopamine.  In addition,  the priming 
stimulation enhances running speed in a frequency-
dependent manner.  Thus,  the dopamine release caused 
by priming stimulation is classiﬁed as a phasic dop-
amine release and motivation might be enhanced 
depending on the degree or frequency of this phasic 
dopamine release.  However,  priming stimulations do 
not act as rewards,  although priming stimulation and 
reward stimulation are the same in terms of dopamine 
release.  It is unclear how rats distinguish the priming 
stimulation from reward,  but this might be explained 
by diﬀerences in the associations between stimulations 
and operant tasks in the runway model of ICSS.  
There is a need to more precisely study the diﬀer-
ences between the neural activity when rats are given 
only a reward and that when rats are provided both 
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Fig. 1　 Schematic diagrams of the runway ICSS apparatus.  First,  animals receive electrical priming stimulation in the Priming box.  After 
the priming stimulation,  animals are placed in the Start box. Animals run to the Goal lever on the other side of the start box through the 
Runway immediately after the door opens.
motivational stimulation and reward.
　 Eﬀects of dopaminergic agents in the runway 
model of ICSS.
　 The runway ICSS model is based on ICSS behav-
ior produced by intracranial stimulation through an 
indwelling electrode at the level of the medial fore-
brain bundle (MFB).  Since the MFB is one of the 
dopaminergic fascicles from the ventral tegmental area 
to the NAc [32],  dopaminergic agents would be 
expected to aﬀect motivated behavior in this paradigm.  
Thus,  we have primarily focused on the eﬀects of 
dopaminergic agents in the runway ICSS model.  The 
selective dopamine uptake inhibitor GBR12909 and 
dopamine-noradrenaline uptake inhibitor nomifensine 
dose-dependently elevated running speed (i.e.,  motiva-
tion for reward).  Facilitation of the priming stimula-
tion eﬀect should be caused by eﬀects on dopamine 
uptake since GBR12909 and nomifensine are reported 
to elevate NAc dopamine levels and we have also 
reported that the enhancing eﬀects of these drugs 
were inhibited by pretreatment with dopamine antago-
nists [33,  34].  It is well known that NAc dopamine 
levels are involved in reward and motivation and that 
the NAc is a terminal of dopamine neurons expressing 
dopamine transporters [35,  36].  Thus,  dopamine 
uptake inhibition in the NAc should be involved in the 
enhancement of running behavior in the runway method 
of ICSS behavior.
　 On the other hand,  the eﬀects of dopamine recep-
tor agonists on this motivated behavior have been 
shown to be diﬀerent from those produced by dop-
amine uptake inhibitors.  The dopamine D1-like agonist 
SKF38393 or the D2-like agonist quinpirole both sup-
pressed motivated behavior.  In addition,  simultaneous 
administration of SKF38393 and quinpirole exhibited 
additive or synergistic eﬀects compared with single 
administrations.  Thus,  the direct stimulation of either 
D1-like and/or D2-like receptors using dopamine 
agonists failed to enhance motivated behavior in the 
ICSS runway model.  Additional research is required 
to reveal a more precise role of dopamine receptors in 
motivated behavior.  Quinpirole has been reported to 
enhance reward-related operant behaviors such as 
addictive drug-related behavior,  quinpirole self-
administration,  and ICSS lever press behavior [37-
40].  However,  in our previous research,  quinpirole 
and SKF38393 suppressed runway-motivated behavior.  
Therefore,  it is believed that dopamine receptor func-
tion may diﬀer between the motivated behavior in our 
runway model and the reward-acquisition behavior in 
previous reports.  Direct receptor stimulation with 
agonists and indirect stimulation with uptake inhibitors 
seem to produce diﬀerent eﬀects in these operant 
behaviors.
　 For this distinction,  we propose 2 hypotheses.  
First,  diﬀerences in the distribution of the dopamine 
transporter and dopamine receptors may be responsi-
ble for diﬀerences in runway behavior.  Dopamine 
transporters are reported to be localized within the 
NAc,  striatum,  substantia nigra,  and ventral tegmen-
tal area [41].  In comparison,  dopamine receptors 
seem to be present across a variety of brain regions 
[42].  A speciﬁc activation pattern of dopamine recep-
tors is likely required for the production of motivated 
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Fig. 2　 Representative examples of the eﬀects of the priming stimulation and reward stimulation in the runway ICSS model.  In the 
experimental extinction of reward,  rats gradually run slower despite the provision of priming stimulation and this speed reduction is 
reversed by the resupply of reward.  For more information about the experimental extinction of ICSS,  see: Sagara et al.,  Biol Pharm Bull 
(2008) 31(4): 541-545.
behavior.  Simultaneous stimulation of dopamine 
receptors in various brain regions (produced by sys-
temic administration of dopamine receptor agonists) 
may result in a depressant eﬀect on motivated behav-
ior.  Second,  there might exist signiﬁcant diﬀerences 
in terms of NAc neurotransmission between the indi-
rect activation of dopamine neurons caused by 
enhancement of intrinsic dopamine transmission by 
dopamine uptake inhibitors and the direct activation of 
dopamine receptors using dopamine receptor agonists.  
The activity of neurons projecting from the NAc may 
also be diﬀerently regulated by these 2 diﬀerent forms 
of activation,  and it may be necessary to evaluate the 
neural activity downstream from the NAc to better 
understand motivational pathways.  Most neurons in the 
NAc are GABAergic.  Thus,  under the inﬂuence of 
drug treatment,  measuring the eﬀects of MFB electri-
cal stimulation on GABA concentrations in nerve ter-
minals projecting from the NAc may be particularly 
helpful in understanding the activation of motivational 
circuitry.
The Distinction of the Runway Model of ICSS:  
Comparison with Other Motivational Behaviors
　 The runway model of drug self-administration and 
progressive ratio schedules using various rewards are 
commonly used methods to evaluate motivation.  In this 
section,  we compare the behavioral characteristics of 
these models with those of the runway model of ICSS.
　 Runway model of drug self-administration.
　 In the runway model of drug self-administration,  
animals are provided an intravenous injection of addic-
tive drugs instead of electrical stimulation as the 
reward for running behavior.  That is,  the runway 
model of drug self-administration is a methodology to 
assess the animalʼs motivation for getting a drug 
reward.  In a previous study,  Ettenberg et al.  reported 
that trained animals would run to a goal box to seek a 
drug reward,  such as cocaine and heroin [43].  
Dopamine receptors were found to be involved in the 
runway task to receive heroin reward,  at least par-
tially [44,  45].  However,  the drug-seeking,  motiva-
tional behavior seems to vary depending on the type of 
rewarding drug.  Although the reinforcing eﬀects of 
cocaine and heroin are equivalent in the conditioned 
place preference test,  cocaine induced “retreat behav-
ior”,  which is approach-avoidance conﬂict behavior,  
whereas heroin exhibited purely facilitative eﬀects for 
running behavior [46].  Thus,  it is considered that the 
motivational eﬀects of reinforcement on runway oper-
ant behavior may diﬀer depending on the reward (type 
of drug,  natural reward,  or rewarding electrical brain 
stimulation).  Many addictive factors (such as drugs,  
gambling,  and sex) are known for activating dopamine 
neurons in brain reward centers [47].  It is suggested 
that addictive drugs would aﬀect motivation through 
the dopaminergic pathway.  However,  it is diﬃcult to 
determine the precise receptors underlying the moti-
vational mechanisms in the runway model of drug self-
administration since addictive drugs act on various 
receptors.  The runway model of ICSS may be more 
suitable for research focusing on the function of the 
dopaminergic system on motivation.  In other words,  
the runway model of drug self-administration would be 
useful to evaluate motivational eﬀects,  considering the 
complex reinforcing properties of addictive drugs.
　 Progressive ratio operant paradigm using 
self-administration of reinforcers.
　 The progressive-ratio paradigm of reinforcement 
was developed by Hodos (1961) [48] to study the 
“relative reward strength of stimulation” and has been 
employed in many studies using rats [49],  monkeys 
[50],  dogs [51],  pigeons [52],  and pigs [53].  Diverse 
reinforcers,  including intravenous injection of psycho-
stimulants [54,  55],  food pellets [56],  liquids [57],  
and intracranial electrical stimulation [58] have been 
used in this paradigm.  The relative responsiveness to 
reinforcements is reported to be diﬀerent among 
reinforcers [59-61].  For example,  electrical stimu-
lation may be more responsive than natural rewards,  
such as sucrose reinforcement [62].  A progressive-
ratio procedure measures the performance of an 
increasing amount of work (progressively increasing 
number of required operant responses) as the eﬀec-
tiveness of reinforcement.  As animals execute the 
operant task,  the magnitude of the task (such as lever 
pressing) required for obtaining a reward increases.  
When the expense of the ever-increasing operant task 
exceeds the value or attraction of the oﬀered reward,  
animals will give up reward acquisition and no longer 
perform the task.  This “breaking point” is one end-
point measure in the progressive ratio procedure.  The 
breaking point is deﬁned as the number of rewards 
acquired during an operant session before the subjects 
cease the operant behavior.  The breaking point is 
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considered to reﬂect the eﬃcacy of the reward and the 
motivation for acquisition of the reward [62].
　 Progressive ratio studies during withdrawal from 
addictive drugs have been reported throughout the 
literature [59,  62].  Under a withdrawal condition for 
d-amphetamine or nicotine,  the breaking point on a 
progressive ratio schedule for sucrose reward exhibits 
a transitory decrease without changing the total sucrose 
consumption.  The decrease in the breaking point sug-
gests that the reward value of sucrose or the motiva-
tion for sucrose is decreased.  However,  this decrease 
in motivation in the progressive ratio seems to be 
slightly diﬀerent from the decrease in the priming 
stimulation eﬀect (the main motivation-regulating fac-
tor) in the runway ICSS model.  The reduced breaking 
point in the progressive ratio strategy is improved by 
antidepressants [63,  64] whereas the priming stimu-
lation eﬀect is reduced by antidepressants.  Therefore,  
these two experimental strategies may evaluate com-
pletely diﬀerent neurobiological functions.
Conclusion
　 In this review,  we discussed the involvement of 
dopamine in various experimental methods to evaluate 
motivation.  The involvement of dopamine in motivated 
behavior appears to be somewhat diﬀerent from its 
role in reward-acquisition behavior.  Appropriate drug 
treatments aﬀecting the dopaminergic system might 
modulate motivation without altering reward process-
ing.  In addition,  assessment methods for motivated 
behavior seem to be pharmacologically distinct.  
Additional research will help reveal more detailed 
characteristics of these experimental models and the 
pharmacological characteristics of motivated behavior 
that are shared across these experimental models.
References
 1. Werner-Seidler A,  Banks R,  Dunn BD and Moulds ML: An investi-
gation of the relationship between positive aﬀect regulation and 
depression.  Behav Res Ther (2013) 51: 46-56.
 2. Jordan LL,  Zahodne LB,  Okun MS and Bowers D: Hedonic and 
behavioral deﬁcits associated with apathy in Parkinsonʼs disease:  
potential treatment implications.  Movement disorders: oﬃcial jour-
nal of the Mov Disord Society (2013) 28: 1301-1304.
 3. Baik JH: Dopamine signaling in reward-related behaviors.  Front 
Neural Circuits (2013) 7: 152.
 4. Day JJ,  Childs D,  Guzman-Karlsson MC,  Kibe M,  Moulden J,  
Song E,  Tahir A and Sweatt JD: DNA methylation regulates asso-
ciative reward learning.  Nat Neurosci (2013) 16: 1445-1452.
 5. Fiorillo CD: Two dimensions of value: dopamine neurons repre-
sent reward but not aversiveness.  Science (2013) 341: 546-549.
 6. Sagara H,  Sendo T and Gomita Y: Evaluation of motivational 
eﬀects induced by intracranial self-stimulation behavior.  Acta Med 
Okayama (2010) 64: 267-275.
 7. Esumi S,  Sagara H,  Nakamoto A,  Kawasaki Y,  Gomita Y and 
Sendo T: Eﬀect of GBR12909 on aﬀective behavior: distinguishing 
motivational behavior from antidepressant-like and addiction-like 
behavior using the runway model of intracranial self-stimulation.  
Behav Brain Res (2013) 243: 313-321.
 8. Martel P and Fantino M: Inﬂuence of the amount of food ingested 
on mesolimbic dopaminergic system activity: a microdialysis study.  
Pharmacol Biochem Behav (1996) 55: 297-302.
 9. Martel P and Fantino M: Mesolimbic dopaminergic system activity 
as a function of food reward: a microdialysis study.  Pharmacol 
Biochem Behav (1996) 53: 221-226.
10. Fiorino DF,  Coury A and Phillips AG: Dynamic changes in 
nucleus accumbens dopamine eﬄux during the Coolidge eﬀect in 
male rats.  J Neurosci (1997) 17: 4849-4855.
11. Devine DP,  Leone P,  Pocock D and Wise RA: Diﬀerential involve-
ment of ventral tegmental mu,  delta and kappa opioid receptors in 
modulation of basal mesolimbic dopamine release: in vivo microdi-
alysis studies.  J Pharmacol Exp Ther (1993) 266: 1236-1246.
12. Hoebel BG,  Monaco AP,  Hernandez L,  Aulisi EF,  Stanley BG 
and Lenard L: Self-injection of amphetamine directly into the brain.  
Psychopharmacology (Berl) (1983) 81: 158-163.
13. Glick SD,  Maisonneuve IM,  Visker KE,  Fritz KA,  Bandarage UK 
and Kuehne ME: 18-Methoxycoronardine attenuates nicotine-
induced dopamine release and nicotine preferences in rats.  
Psychopharmacology (Berl) (1998) 139: 274-280.
14. Fiorino DF,  Coury A,  Fibiger HC and Phillips AG: Electrical stim-
ulation of reward sites in the ventral tegmental area increases dop-
amine transmission in the nucleus accumbens of the rat.  Behav 
Brain Res (1993) 55: 131-141.
15. Nakahara D,  Fuchikami K,  Ozaki N,  Iwasaki T and Nagatsu T:  
Diﬀerential eﬀect of self-stimulation on dopamine release and 
metabolism in the rat medial frontal cortex,  nucleus accumbens 
and striatum studied by in vivo microdialysis.  Brain res (1992) 574:  
164-170.
16. Phillips AG,  Coury A,  Fiorino D,  LePiane FG,  Brown E and 
Fibiger HC: Self-stimulation of the ventral tegmental area enhances 
dopamine release in the nucleus accumbens: a microdialysis study.  
Ann N Y Acad Sci (1992) 654: 199-206.
17. Westerink BH: Brain microdialysis and its application for the study 
of animal behaviour.  Behav Brain Res (1995) 70: 103-124.
18. Kruk ZL,  Cheeta S,  Milla J,  Muscat R,  Williams JE and Willner P:  
Real time measurement of stimulated dopamine release in the con-
scious rat using fast cyclic voltammetry: dopamine release is not 
observed during intracranial self stimulation.  J Neurosci Methods 
(1998) 79: 9-19.
19. Miliaressis E,  Emond C and Merali Z: Re-evaluation of the role of 
dopamine in intracranial self-stimulation using in vivo microdialysis.  
Behav Brain Res (1991) 46: 43-48.
20. Garris PA,  Kilpatrick M,  Bunin MA,  Michael D,  Walker QD and 
Wightman RM: Dissociation of dopamine release in the nucleus 
accumbens from intracranial self-stimulation.  Nature (1999) 398:  
67-69.
21. Kilpatrick MR,  Rooney MB,  Michael DJ and Wightman RM:  
Extracellular dopamine dynamics in rat caudate-putamen during 
experimenter-delivered and intracranial self-stimulation.  Neuro-
260 Acta Med.  Okayama　Vol.  68,  No.  5Esumi et al.
science (2000) 96: 697-706.
22. Owesson-White CA,  Cheer JF,  Beyene M,  Carelli RM and 
Wightman RM: Dynamic changes in accumbens dopamine corre-
late with learning during intracranial self-stimulation.  Proc Natl 
Acad Sci U S A (2008) 105: 11957-11962.
23. Flagel SB,  Clark JJ,  Robinson TE,  Mayo L,  Czuj A,  Willuhn I,  
Akers CA,  Clinton SM,  Phillips PE and Akil H: A selective role 
for dopamine in stimulus-reward learning.  Nature (2011) 469: 53-
57.
24. Grace AA and Bunney BS: The control of ﬁring pattern in nigral 
dopamine neurons: burst ﬁring.  J Neurosci (1984) 4: 2877-2890.
25. Grace AA and Bunney BS: The control of ﬁring pattern in nigral 
dopamine neurons: single spike ﬁring.  J Neurosci (1984) 4: 2866-
2876.
26. Floresco SB,  West AR,  Ash B,  Moore H and Grace AA: Aﬀerent 
modulation of dopamine neuron ﬁring diﬀerentially regulates tonic 
and phasic dopamine transmission.  Nat Neurosci (2003) 6: 968-
973.
27. Goto Y and Grace AA: Dopaminergic modulation of limbic and 
cortical drive of nucleus accumbens in goal-directed behavior.  Nat 
Neurosci (2005) 8: 805-812.
28. Zweifel LS,  Parker JG,  Lobb CJ,  Rainwater A,  Wall VZ,  Fadok 
JP,  Darvas M,  Kim MJ,  Mizumori SJ,  Paladini CA,  Phillips PE 
and Palmiter RD: Disruption of NMDAR-dependent burst ﬁring by 
dopamine neurons provides selective assessment of phasic dop-
amine-dependent behavior.  Proc Natl Acad Sci U S A (2009) 106:  
7281-7288.
29. Dreyer JK,  Herrik KF,  Berg RW and Hounsgaard JD: Inﬂuence of 
phasic and tonic dopamine release on receptor activation.  J 
Neurosci (2010) 30: 14273-14283.
30. Grieder TE,  George O,  Tan H,  George SR,  Le Foll B,  Laviolette 
SR and van der Kooy D: Phasic D1 and tonic D2 dopamine recep-
tor signaling double dissociate the motivational eﬀects of acute 
nicotine and chronic nicotine withdrawal.  Proc Natl Acad Sci U S 
A (2012) 109: 3101-3106.
31. Hart AS,  Rutledge RB,  Glimcher PW and Phillips PE: Phasic 
dopamine release in the rat nucleus accumbens symmetrically 
encodes a reward prediction error term.  J Neurosci (2014) 34:  
698-704.
32. Gardner EL: Addiction and brain reward and antireward pathways.  
Adv Psychosom Med (2011) 30: 22-60.
33. Zolkowska D,  Jain R,  Rothman RB,  Partilla JS,  Roth BL,  Setola V,  
Prisinzano TE and Baumann MH: Evidence for the involvement of 
dopamine transporters in behavioral stimulant eﬀects of modaﬁnil.  
J Pharmacol Exp Ther (2009) 329: 738-746.
34. Esumi S,  Kawasaki Y,  Nakamoto A,  Sagara H,  Gomita Y,  
Kitamura Y and Sendo T: Diﬀerential eﬀects of nomifensine and 
imipramine on motivated behavior in the runway model of intracra-
nial self-stimulation.  Eur J Pharmacol (2013) 720: 186-191.
35. Carlezon WA,  Jr.  and Thomas MJ: Biological substrates of reward 
and aversion: a nucleus accumbens activity hypothesis.  Neuro-
pharmacology (2009) 56 Suppl 1: 122-132.
36. Nirenberg MJ,  Chan J,  Pohorille A,  Vaughan RA,  Uhl GR,  Kuhar 
MJ and Pickel VM: The dopamine transporter: comparative ultra-
structure of dopaminergic axons in limbic and motor compartments 
of the nucleus accumbens.  J Neurosci (1997) 17: 6899-6907.
37. Edwards S,  Whisler KN,  Fuller DC,  Orsulak PJ and Self DW:  
Addiction-related alterations in D1 and D2 dopamine receptor 
behavioral responses following chronic cocaine self-administration.  
Neuropsychopharmacology (2007) 32: 354-366.
38. Koeltzow TE and Vezina P: Locomotor activity and cocaine-seek-
ing behavior during acquisition and reinstatement of operant self-
administration behavior in rats.  Behav Brain Res (2005) 160: 250-
259.
39. Grech DM,  Spealman RD and Bergman J: Self-administration of 
D1 receptor agonists by squirrel monkeys.  Psychopharmacology 
(Berl) (1996) 125: 97-104.
40. Nakajima S,  Liu X and Lau CL: Synergistic interaction of D1 and 
D2 dopamine receptors in the modulation of the reinforcing eﬀect 
of brain stimulation.  Behav Neurosci (1993) 107: 161-165.
41. Ciliax BJ,  Heilman C,  Demchyshyn LL,  Pristupa ZB,  Ince E,  
Hersch SM,  Niznik HB and Levey AI: The dopamine transporter:  
immunochemical characterization and localization in brain.  J 
Neurosci (1995) 15: 1714-1723.
42. Weiner DM,  Levey AI,  Sunahara RK,  Niznik HB,  OʼDowd BF,  
Seeman P and Brann MR: D1 and D2 dopamine receptor mRNA in 
rat brain.  Proc Natl Acad Sci U S A (1991) 88: 1859-1863.
43. Ettenberg A: The runway model of drug self-administration.  
Pharmacol Biochem Behav (2009) 91: 271-277.
44. Ettenberg A and McFarland K: Eﬀects of haloperidol on cue-
induced autonomic and behavioral indices of heroin reward and 
motivation.  Psychopharmacology (Berl) (2003) 168: 139-145.
45. McFarland K and Ettenberg A: Haloperidol diﬀerentially aﬀects 
reinforcement and motivational processes in rats running an alley 
for intravenous heroin.  Psychopharmacology (Berl) (1995) 122:  
346-350.
46. Su ZI,  Wenzel J,  Baird R and Ettenberg A: Comparison of self-
administration behavior and responsiveness to drug-paired cues in 
rats running an alley for intravenous heroin and cocaine.  Psycho-
pharmacology (Berl) (2011) 214: 769-778.
47. Blum K,  Chen AL,  Giordano J,  Borsten J,  Chen TJ,  Hauser M,  
Simpatico T,  Femino J,  Braverman ER and Barh D: The addictive 
brain: all roads lead to dopamine.  J Psychoactive drugs (2012) 44:  
134-143.
48. Hodos W: Progressive ratio as a measure of reward strength.  
Science (1961) 134: 943-944.
49. Roberts DC,  Loh EA and Vickers G: Self-administration of cocaine 
on a progressive ratio schedule in rats: dose-response relationship 
and eﬀect of haloperidol pretreatment.  Psychopharmacology (Berl) 
(1989) 97: 535-538.
50. Griﬃths RR,  Brady JV and Snell JD: Progressive-ratio performance 
maintained by drug infusions: comparison of cocaine,  diethylpro-
pion,  chlorphentermine,  and fenﬂuramine.  Psychopharmacology 
(Berl) (1978) 56: 5-13.
51. Risner ME and Silcox DL: Psychostimulant self-administration by 
beagle dogs in a progressive-ratio paradigm.  Psychopharmacology 
(Berl) (1981) 75: 25-30.
52. Wanchisen BA,  Tatham TA and Hineline PN: Pigeonsʼ choices in 
situations of diminishing returns: ﬁxed- versus progressive-ratio 
schedules.  J Exp Anal Behav (1988) 50: 375-394.
53. Dantzer R: Eﬀect of diazepam on performance of pigs in a pro-
gressive ratio schedule.  Physiology & behavior (1976) 17: 161-
163.
54. Winger G and Woods JH: Comparison of ﬁxed-ratio and progres-
sive-ratio schedules of maintenance of stimulant drug-reinforced 
responding.  Drug Alcohol Depend (1985) 15: 123-130.
55. Depoortere RY,  Li DH,  Lane JD and Emmett-Oglesby MW:  
Parameters of self-administration of cocaine in rats under a pro-
gressive-ratio schedule.  Pharmacol Biochem Behav (1993) 45:  
539-548.
56. Depoortere R,  Perrault G and Sanger DJ: Behavioural eﬀects in 
the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT:  
261Assessment of Motivational BehaviorsOctober 2014
comparison with quinpirole and apomorphine.  Psychopharmacology 
(Berl) (1996) 124: 231-240.
57. Cheeta S,  Brooks S and Willner P: Eﬀects of reinforcer sweetness 
and the D2/D3 antagonist raclopride on progressive ratio operant 
performance.  Behav Pharmacol (1995) 6: 127-132.
58. Depoortere R,  Perrault G and Sanger DJ: Intracranial self-stimula-
tion under a progressive-ratio schedule in rats: eﬀects of strength 
of stimulation,  d-amphetamine,  7-OH-DPAT and haloperidol.  Psy-
chopharmacology (Berl) (1999) 142: 221-229.
59. Barr AM and Phillips AG: Withdrawal following repeated exposure 
to d-amphetamine decreases responding for a sucrose solution as 
measured by a progressive ratio schedule of reinforcement.  Psy-
chopharmacology (Berl) (1999) 141: 99-106.
60. Orsini C,  Koob GF and Pulvirenti L: Dopamine partial agonist 
reverses amphetamine withdrawal in rats.  Neuropsycho-
pharmacology (2001) 25: 789-792.
61. Russig H,  Pezze MA,  Nanz-Bahr NI,  Pryce CR,  Feldon J and 
Murphy CA: Amphetamine withdrawal does not produce a depres-
sive-like state in rats as measured by three behavioral tests.  Behav 
Pharmacol (2003) 14: 1-18.
62. LeSage MG,  Burroughs D and Pentel PR: Eﬀects of nicotine with-
drawal on performance under a progressive-ratio schedule of 
sucrose pellet delivery in rats.  Pharmacol Biochem Behav (2006) 
83: 585-591.
63. Kokkinidis L,  Zacharko RM and Predy PA: Post-amphetamine 
depression of self-stimulation responding from the substantia nigra:  
reversal by tricyclic antidepressants.  Pharmacol Biochem Behav 
(1980) 13: 379-383.
64. Markou A and Koob GF: Postcocaine anhedonia.  An animal model 
of cocaine withdrawal.  Neuropsychopharmacology (1991) 4: 17-
26.
262 Acta Med.  Okayama　Vol.  68,  No.  5Esumi et al.
